DistillerSR Launches Industry’s First Purpose-built GenAI Solution for Literature Reviews

2 hours ago 1

Author of the article:

Business Wire

Published Nov 18, 2024  •  3 minute read

media

Smart Evidence Extraction (SEE) Accurately Finds, Suggests, Extracts, and Links Supporting Reference Evidence Instantly for Literature Reviews

BARCELONA, Spain — DistillerSR Inc., the market leader in AI-enabled literature review software and creator of DistillerSR®, today announced the availability of Smart Evidence Extraction (SEE)™, the industry’s first purpose-built GenAI solution for literature reviews. Depending on the subject matter, researchers generally take 2-3 hours to critically read and appraise a scientific journal’s findings, which, over the course of hundreds and thousands of references analyzed during a literature review, can lead to human fatigue and errors. With SEE, it now takes just a few seconds to extract and link the supporting evidence from scientific papers.

Advertisement 2

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

SEE is a composite AI technology, blending traditional AI and GenAI models. This approach addresses the information overload and context-noise issues faced by traditional GenAI models, providing faster, higher quality answer suggestions. Integrated into DistillerSR’s auditable workflow to ensure complete regulatory compliance and efficient human-in-loop oversight, SEE automatically extracts content to answer both closed and open-ended questions, including numerical content, sentiment analysis, risk of bias information and study summaries. SEE’s composite AI approach grounds the creativity of current GenAI models restricting response content to only the paper being reviewed.

“We’ve incorporated AI into the DistillerSR platform since 2016,” said Peter O’Blenis, CEO, DistillerSR Inc. “We view AI as part of our technology stack, integrated seamlessly within DistillerSR’s powerful workflow and evidence management platform, to dramatically accelerate the literature review process while still addressing the critical regulatory requirements of our customers. SEE is the next logical step in the evolution of AI in literature reviews.”

SEE incorporates comprehensive controls to manage copyright adherence, while ensuring that all data remains securely within the DistillerSR platform and is not shared with third-party GenAI vendors. In September of this year, DistillerSR adopted the NIST AI Risk Management Framework (RMF) to govern its AI models and third-party vendors. The framework allows customers and prospects to evaluate how the company governs the engineering, privacy, and ethical dimensions of newly developed AI features and their application to enhance health research.

Literature reviews are the cornerstone of evidence-based research; however, their production has traditionally been highly manual, time consuming, and error prone. In recent years, technology companies have attempted to apply large language models (LLMs) to extract and summarize scientific literature and clinical data. Most LLMs, however, generate significant inaccuracies, often called “hallucinations”, which can lead to serious data errors in regulatory submissions, scientific communications, and guideline development.

SEE provides researchers with a purpose-built GenAI solution that is integrated into an auditable and efficient human-in-the-loop literature review workflow. SEE’s proprietary technology grounds the creative nature of GenAI, making it more context aware and focused only on extracting data specific to the literature being reviewed.

Advertisement 3

Article content

From November 18-20th, DistillerSR will demonstrate SEE to ISPOR Europe conference attendees at booth 512. ISPOR is the Professional Society for Health Economics and Outcomes Research. The non-profit organization is the world’s largest professional society for health economics and outcomes research professionals.

Today, 80% of the world’s largest pharmaceutical and medical device companies trust DistillerSR to securely produce transparent, audit-ready, and regulatory compliant literature reviews. The DistillerSR platform and modular ecosystem enable our customers to securely automate the management and analysis of evidence-based research — faster, more accurately, more transparently, and at scale.

About DistillerSR Inc.
Visit www.distillersr.com.

® DistillerSR Inc. is a registered trademark of DistillerSR Inc.
™ Smart Evidence Extraction is a trademark of DistillerSR Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241118159269/en/

logo

Contacts

DistillerSR Inc. Media Contact
Chris Wright
[email protected]

Article content

Read Entire Article